Moreover, Wild and Bartholomew revealed that in women with PCOS altered glucose-insulin homeostasis is a stronger contributor to dyslipidaemia than hyperandrogenemia or chronic high estrogen exposure [16]. The gene discussed is INS; the disease is polycystic ovary syndrome.